[
  {
    "ts": null,
    "headline": "Why Medtronic Stock Marched Higher on Monday",
    "summary": "Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by almost 3% in value.  On Sunday, Medtronic published five-year data from a low-risk clinical trial of its Evolut transcatheter aortic valve replacement (TAVR) system.  In the trial, TAVR, which assists patients suffering from the heart valve disorder aortic stenosis, was tested against surgical aortic vale replacement (SAVR).",
    "url": "https://finnhub.io/api/news?id=84987fdb197bd924e204613bf004bf2b5b5b56d46385ca7039f12d062d50312d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743459088,
      "headline": "Why Medtronic Stock Marched Higher on Monday",
      "id": 133633088,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by almost 3% in value.  On Sunday, Medtronic published five-year data from a low-risk clinical trial of its Evolut transcatheter aortic valve replacement (TAVR) system.  In the trial, TAVR, which assists patients suffering from the heart valve disorder aortic stenosis, was tested against surgical aortic vale replacement (SAVR).",
      "url": "https://finnhub.io/api/news?id=84987fdb197bd924e204613bf004bf2b5b5b56d46385ca7039f12d062d50312d"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic (NYSE:MDT) TAVR System Shows Strong Five-Year Performance Despite 3% Price Dip",
    "summary": "Medtronic (NYSE:MDT) recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by the release of promising five-year data from the Evolut Low Risk Trial, which indicated favorable outcomes for the company's transcatheter aortic valve replacement system compared to surgery. Further boosting investor sentiment was the FDA approval of Medtronic's BrainSense technology, enhancing treatment for Parkinson's disease. Despite challenging overall market...",
    "url": "https://finnhub.io/api/news?id=28165ce56e95298a03e6a67d07d41a86972e48abfe2dcb1de17283d7dd83ba79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743441691,
      "headline": "Medtronic (NYSE:MDT) TAVR System Shows Strong Five-Year Performance Despite 3% Price Dip",
      "id": 133627905,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (NYSE:MDT) recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by the release of promising five-year data from the Evolut Low Risk Trial, which indicated favorable outcomes for the company's transcatheter aortic valve replacement system compared to surgery. Further boosting investor sentiment was the FDA approval of Medtronic's BrainSense technology, enhancing treatment for Parkinson's disease. Despite challenging overall market...",
      "url": "https://finnhub.io/api/news?id=28165ce56e95298a03e6a67d07d41a86972e48abfe2dcb1de17283d7dd83ba79"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Reports for Mastercard, Medtronic & HCA Healthcare",
    "summary": "Today's Research Daily features new research reports on 12 major stocks, including Mastercard Incorporated (MA), Medtronic plc (MDT) and HCA Healthcare, Inc. (HCA), as well as a micro-cap stock United Homes Group, Inc. (UHG).",
    "url": "https://finnhub.io/api/news?id=f06a770d640ab7140c223dc009f092b812eca8d576256434d02b64488bfcaab7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743439320,
      "headline": "Top Stock Reports for Mastercard, Medtronic & HCA Healthcare",
      "id": 133632951,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Today's Research Daily features new research reports on 12 major stocks, including Mastercard Incorporated (MA), Medtronic plc (MDT) and HCA Healthcare, Inc. (HCA), as well as a micro-cap stock United Homes Group, Inc. (UHG).",
      "url": "https://finnhub.io/api/news?id=f06a770d640ab7140c223dc009f092b812eca8d576256434d02b64488bfcaab7"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic PLC stock outperforms competitors on strong trading day",
    "summary": "Medtronic PLC stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=eb22b7374b04d29a8cdac2856a0763f735961d4f785d16aee01869da0497a53d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743439020,
      "headline": "Medtronic PLC stock outperforms competitors on strong trading day",
      "id": 133639001,
      "image": "",
      "related": "MDT",
      "source": "MarketWatch",
      "summary": "Medtronic PLC stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=eb22b7374b04d29a8cdac2856a0763f735961d4f785d16aee01869da0497a53d"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Aristocrats For April 2025",
    "summary": "Dividend Aristocrats in 2025 show resilience, outperforming the S&P 500. Click here to read what investors need to know.",
    "url": "https://finnhub.io/api/news?id=8d2f7e6be3053b554cc8ee87405abf96ff95f26b38f72e7f7cdf82cef0d639bd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743437243,
      "headline": "Best Dividend Aristocrats For April 2025",
      "id": 133629387,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2165465384/image_2165465384.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "Dividend Aristocrats in 2025 show resilience, outperforming the S&P 500. Click here to read what investors need to know.",
      "url": "https://finnhub.io/api/news?id=8d2f7e6be3053b554cc8ee87405abf96ff95f26b38f72e7f7cdf82cef0d639bd"
    }
  },
  {
    "ts": null,
    "headline": "GE HealthCare's Latest Product Launch to Boost Cardiology Care",
    "summary": "GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.",
    "url": "https://finnhub.io/api/news?id=81f3a3e72edf57bcd70a741b0699bd7fb3e190093b2aecbb94a3bc7c7c889162",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743428700,
      "headline": "GE HealthCare's Latest Product Launch to Boost Cardiology Care",
      "id": 133627816,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.",
      "url": "https://finnhub.io/api/news?id=81f3a3e72edf57bcd70a741b0699bd7fb3e190093b2aecbb94a3bc7c7c889162"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic : announces strategic partnership with Methinks AI to advance stroke care development",
    "summary": "Medtronic, a global leader in healthcare technology, announced a partnership with Methinks AI, a leading AI-driven radiological triage and notification system provider to enhance stroke treatment...",
    "url": "https://finnhub.io/api/news?id=c94b4a898b2e54f2b393c6bf80bd26466fb2519858314dc782008321f4d83c13",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743413409,
      "headline": "Medtronic : announces strategic partnership with Methinks AI to advance stroke care development",
      "id": 133626220,
      "image": "",
      "related": "MDT",
      "source": "Finnhub",
      "summary": "Medtronic, a global leader in healthcare technology, announced a partnership with Methinks AI, a leading AI-driven radiological triage and notification system provider to enhance stroke treatment...",
      "url": "https://finnhub.io/api/news?id=c94b4a898b2e54f2b393c6bf80bd26466fb2519858314dc782008321f4d83c13"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Advantage Large Cap Value Fund Q4 2024 Commentary",
    "summary": "The fund posted returns of -2.24%Â (Institutional shares) and -2.30%Â (Investor A shares, without sales charge) for the fourth quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=742833e4e136e5538ec184717e1a5d3648b10ae237a9aa92e84d73739261e7f5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743411600,
      "headline": "BlackRock Advantage Large Cap Value Fund Q4 2024 Commentary",
      "id": 133626115,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "The fund posted returns of -2.24%Â (Institutional shares) and -2.30%Â (Investor A shares, without sales charge) for the fourth quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=742833e4e136e5538ec184717e1a5d3648b10ae237a9aa92e84d73739261e7f5"
    }
  },
  {
    "ts": null,
    "headline": "TransMedics: The Financial Tipping Point That Will Drive Mass Adoption",
    "summary": "TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong buy right now.",
    "url": "https://finnhub.io/api/news?id=29b43b92ceb55fadd74f821c98726f172cee3abf6f42c5d84c4dbe645a2fdcd4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743395997,
      "headline": "TransMedics: The Financial Tipping Point That Will Drive Mass Adoption",
      "id": 133624082,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1439788224/image_1439788224.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong buy right now.",
      "url": "https://finnhub.io/api/news?id=29b43b92ceb55fadd74f821c98726f172cee3abf6f42c5d84c4dbe645a2fdcd4"
    }
  }
]